quercetin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Inhibits DNMT1
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Supplementation with GT + Q compared to GT + PL did not lead to changes in gene and protein expression or enzyme activity of COMT and DNMT in prostate tissue and red blood cells (Tables 4 and 5).”
Quoted verbatim from Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer.. - Study
- RCT
- Duration
- 4 weeks
- Dose
- 800 mg quercetin daily (400 mg twice daily) with 1 g green tea extract, about 4 weeks
- Population
- 31 men with localised prostate cancer before prostatectomy; green tea extract given in both arms, quercetin or placebo added
Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer.2020PMID:32347270Permalink
Keep reading
- Everything the graph holds on quercetin
- Every compound studied against DNMT1
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5RZG83DF3BW1SFGJ9CP6DPZ